Former Pharmacopeia Exec Named COO, President of Senomyx | GenomeWeb

NEW YORK, May 8 – Saiid Zarrabian, who resigned as chief operating officer at Pharmacopeia in December, has been appointed president and COO of Senomyx, a developer of flavor and fragrance molecules that can be used in consumer products, Senomyx said Tuesday.

"Mr. Zarrabian brings tremendous knowledge to Senomyx, particularly in the area of chemical and biological simulations and analysis systems, as well as drug discovery process,” Senomyx CEO Paul Grayson said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.